Kayla Kokal
Family · Peterborough, NHNPI 1790201887
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 127 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 29.9% of the total. Reporting peaked in 2021 at $1,870 and has fallen 97.4% since, to $48 in 2025. Among family clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 127 payments — averaging $17.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$662
- AstraZeneca$215
- Lilly USA, LLC$196
- GSK$116
- Amarin Pharma, Inc.$113
- Eisai Inc.$111
- plus $806 from 18 others
What the payments were for
- Food & beverage$2,218100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 39 | $662 |
| AstraZeneca | 11 | $215 |
| Lilly USA, LLC | 11 | $196 |
| GSK | 7 | $116 |
| Amarin Pharma, Inc. | 8 | $113 |
| Eisai Inc. | 6 | $111 |
| Novo Nordisk | 5 | $96 |
| Teva Pharmaceuticals USA, Inc. | 5 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Boehringer Ingelheim | 4 | $74 |
| Amgen | 4 | $72 |
| Biohaven Pharmaceuticals, Inc. | 4 | $67 |
| Merck | 2 | $47 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Johnson & Johnson | 2 | $35 |
| Pfizer | 2 | $29 |
| Neurocrine Biosciences, Inc. | 2 | $28 |
| Astellas Pharma US Inc | 1 | $21 |
| Medtronic | 1 | $21 |
| Biogen | 1 | $20 |
| Biodelivery Sciences International, Inc. | 1 | $19 |
| Exact Sciences | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $12 |
How this compares
$2,218 in reported general payments places this provider in the 90th percentile of 713 family providers in New Hampshire.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 36 | $39,360 |
| FarxigaDapagliflozin Propanediol | 18 | $12,384 |
| JardianceEmpagliflozin | 14 | $8,208 |
| Methylphenidate ErMethylphenidate Hcl | 12 | $6,382 |
| RocklatanNetarsudil Mesylat/Latanoprost | 14 | $5,135 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 98 | $2,715 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 22 | $2,014 |
| Levothyroxine Sodium | 154 | $1,663 |
| Atorvastatin Calcium | 152 | $1,637 |
| Lisinopril | 170 | $1,503 |
| Omeprazole | 86 | $1,289 |
| SynthroidLevothyroxine Sodium | 15 | $1,288 |
| Metoprolol Succinate | 61 | $1,232 |
| Trazodone Hcl | 59 | $1,225 |
| Duloxetine Hcl | 37 | $1,001 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $29 | $39,36036 claims |
| AstraZenecaFarxiga | $215 | $12,38418 claims |
| Boehringer IngelheimJardiance | $74 | $8,20814 claims |
| AbbVieSynthroid | $662 | $1,28815 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 713 family providers in New Hampshire.
Other family in Peterborough
- Brian CromerPeterborough$4K
- Tara Delle ChiaieHampton$548K
- Wendy WrightAmherst$447K
- Richard CareyNashua$51K
- Summer BellDerry$16K
- Laura HudsonDover$14K
- Debra KrisonNorth Hampton$13K
- Michelle WhiteBedford$9K
- Brant OliverConcord$9K
- Cassandra CavanaughDover$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.